ELOCTATE

Google image searchProduct monograph

Active ingredient

antihemophilic factor (recombinant bdd), fc fusion protein, 750 UNIT/VIAL

DIN: 02430312

Dosage form(s): KIT, POWDER FOR SOLUTION

Route(s) of administration: INTRAVENOUS

Description: SINGLE-USE VIAL (POWDER), PRE-FILLED SYRINGE (DILUENT)

Schedule: Schedule D

Company: SANOFI-AVENTIS CANADA INC

Date: 10-SEP-2021

ATC:

• B02 — ANTIHEMORRHAGICS (ATC, ATC/DDD, )
• B02B — VITAMIN K AND OTHER HEMOSTATICS (ATC, ATC/DDD)
• B02BD — Blood coagulation factors (ATC, ATC/DDD)
• B02BD02 — COAGULATION FACTOR VIII (ATC/DDD)

Reference brand drug: Adynovate, Eloctate, Esperoct, Jivi, Kovaltry, Nuwiq, Obizur, Xyntha, Zonovate

External Links for Eloctate

Search on Google

• Eloctate side effects
• Eloctate dosage
• antihemophilic factor side effects
• antihemophilic factor dosage

Sanofi-Aventis Canada Inc

Go to Sanofi-Aventis website to see drug product details. Sometimes you can find eloctate photos and/or monograph. If you are a healthcare professional, you may need to enter your license number.